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Intracellular persistence of mycobacteria may result from an intricate balance between bacterial replication
and signaling events leading to antimicrobial macrophage activities. Using human monocyte-derived macro-
phages, we investigated the relevance of mitogen-activated protein kinase activation for the growth control of
Mycobacterium avium isolates differing in their abilities to multiply intracellularly. The highly replicative
smooth transparent morphotype of M. avium strain 2151 induced significantly less p38 and extracellular
signal-regulated kinases 1 and 2 (ERK1/2) phosphorylation than the smooth opaque morphotype of the same
strain, which was gradually eliminated from macrophage cultures. Inhibition of the p38 pathway by highly
specific inhibitors did not significantly affect mycobacterial replication within macrophages, regardless of the
in vitro virulence of the M. avium strain. However, repression of the ERK1/2 pathway further enhanced
intracellular growth of highly replicative M. avium strains, although it did not increase survival of the poorly
replicating M. avium isolate. Inhibition of the ERK1/2 pathway resulted in decreased tumor necrosis alpha
(TNF-) secretion irrespective of the virulence of the M. avium isolate used for infection, revealing that TNF-
could have been only partially responsible for the control of intracellular M. avium growth. In conclusion,
ERK1/2- and TNF--independent pathways are sufficient to limit intramacrophage growth of less-virulent M.
avium strains, but early ERK1/2 activation in infected macrophages is critically involved in controlling the
growth of highly replicative M. avium strains.
Macrophages play a central role in the first line of defense
against pathogenic microorganisms because they are critically
involved in the activation of both innate and acquired immune
responses. Following phagocytosis, macrophages become acti-
vated to initiate defense mechanisms, e.g., production of nitric
oxide and phagosome acidification, that ultimately lead to the
degradation of many microbial species (33; reviewed in refer-
ence 19). Paradoxically, macrophages are also the key target
cells of a variety of pathogens, e.g., mycobacteria, that have
developed strategies to invade macrophages and replicate in-
tracellularly.
Infections with mycobacteria, such as tuberculosis, are char-
acterized by their chronic course. Both human and mouse
studies have provided ample evidence that even in the face of
an adequate immune response, mycobacteria like Mycobacte-
rium tuberculosis and Mycobacterium avium are able to persist
inside macrophages (13; reviewed in reference 20). Of interest,
several strains and distinct morphotypes (smooth transparent,
smooth opaque) of M. avium differ with respect to virulence
and persistence in an in vivo infection model (25). One poten-
tial mechanism by which virulent mycobacterial strains, as op-
posed to avirulent strains, may achieve a state of long-term
persistence is the modulation of signaling cascades leading to
macrophage activation (reviewed in reference 23).
Diverse signaling cascades are involved in triggering cellular
responses to pathogenic organisms (reviewed in reference 22).
One essential branch of cell signaling in eucaryotic organisms
is the ubiquitously expressed family of mitogen-activated pro-
tein (MAP) kinases (reviewed in reference 7). These serine/
threonine kinases are critically involved in cell proliferation,
differentiation, and cell death, as well as the inflammatory
response (reviewed in reference 17). In mammals there are
three subfamilies of MAP kinases that can be activated inde-
pendently and simultaneously: p46 and p54 c-Jun-NH2-termi-
nal kinases, p42 and p44 extracellular signal-regulated kinases
1 and 2 (ERK1/2), and p38 MAP kinase (reviewed in reference
5). MAP kinases mediate cellular responses to a variety of
extracellular stimuli, such as physical stress (e.g., osmotic
changes), inflammatory cytokines, growth factors, and bacte-
rial components (e.g., lipopolysaccharide [LPS]) (reviewed in
reference 18). Highly specific, cell-permeable inhibitors of
MAP kinase activity have been useful tools in identifying some
physiological functions of these signaling cascades in terms of
infectious processes. By using these inhibitors, the life cycles of
some viruses, e.g., human immunodeficiency virus, were deter-
mined to depend on ERK1/2 and p38 MAP kinase activity (29,
32, 34). ERK1/2 activity was also shown to be critically involved
in invasion of the facultative intracellular bacterium Listeria
monocytogenes, but not Salmonella enterica serovar Typhi-
murium (31). Even growth of some tumors in vivo was success-
fully blocked by MAP kinase inhibitors (28).
The activation of MAP kinase signaling cascades by myco-
bacterial components (6, 15) as well as viable M. avium (26)
has only recently been described. However, the functional rel-
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evance of MAP kinase activity with respect to uptake and
intracellular persistence of mycobacteria has remained unex-
plored. In particular, it is unknown whether there is a direct
correlation between the magnitude of MAP kinase activation
and the magnitude of intracellular replication of different M.
avium strains or morphotypes. In this study, we investigated
whether highly specific MAP kinase inhibitors would interfere
with intramacrophage growth and cytokine induction of M.
avium strains differing in their in vitro replication rates.
MATERIALS AND METHODS
Bacteria. M. avium strains 2151 (morphotypes smooth transparent and smooth
opaque) and SE01 were originally isolated from AIDS patients (3, 13). Myco-
bacterial strains were grown in Middlebrook 7H9 medium (Difco, Detroit,
Mich.) containing 10% OADC (oleic acid, albumin, dextrose, catalase; Becton
Dickinson) and 0.05% Tween 80 (Sigma, Deisenhofen, Germany) until mid-log
phase. Absence of contaminating microorganisms was verified by plating culture
material on brain heart infusion agar (Difco) and Ziehl-Neelsen staining. The
suspension was frozen in aliquots at 70°C until use. For calculation of CFU,
aliquots were serially diluted in sterile, distilled water containing 0.05% Tween
80 and plated on 7H10 agar containing 0.075% pyruvate (Sigma). After incuba-
tion for 3 weeks at 37°C, CFU were calculated. For infection, bacterial aliquots
were thawed and centrifuged for 10 min at 835  g. Bacteria were resuspended
in phosphate-buffered saline and sonicated (3 to 5 min, 35 kHz; Bandelin, Berlin,
Germany) to disrupt aggregates. Bacterial LPS of S. enterica serotype Friedenau
H909 was kindly provided by H. Brade (Research Center Borstel, Borstel, Ger-
many).
Inhibitors. PD98059 and SB203580 were purchased from Calbiochem
(Schwalbach, Germany) and used at concentrations of 3 or 10 M. Dimethyl
sulfoxide (DMSO; Sigma) was added to cultures at 0.1% (vol/vol) as solvent
control.
Isolation and cultivation of human monocyte-derived macrophages. Mononu-
clear cells were isolated from the peripheral blood of healthy volunteers by
density gradient centrifugation (4). Lymphocytes and monocytes were separated
by counterflow elutriation as previously described (12). Highly purified (consis-
tently 95%) monocytes were cultivated for 7 days in Teflon culture bags
(CellGenix, Freiburg, Germany) in RPMI 1640 (Biochrom, Berlin, Germany) in
the presence of 2% (vol/vol) heat-inactivated human AB serum, 2 ng of human
macrophage colony-stimulating factor (R&D Systems, Wiesbaden, Germany)
per ml, 2 mmol of L-glutamine (Biochrom) per liter, 100 U of penicillin G per ml,
and 100 g of streptomycin/ml (both from Biochrom). Cell viability was deter-
mined by trypan blue staining. Macrophages were phenotyped by cell surface
marker expression profile (CD14, macrophage mannose receptor, carboxypep-
tidase M, and HLA-DR) as described previously (26). Macrophages were culti-
vated in 24-well flat-bottom microtiter plates (Nunc, Roskilde, Denmark) in
RPMI 1640 containing 10% (vol/vol) heat-inactivated fetal calf serum (Bio-
chrom) and 2 mmol of L-glutamine/liter. Cultures were incubated at 37°C in a
humidified atmosphere containing 5% CO2.
In vitro infection. A total of 2.5 105 human macrophages (at a concentration
of 5  105 per ml) were inoculated with 1.25  106 CFU of M. avium 2151 SmT
or 2151 SmO per well, and cultures were incubated in the presence or absence
of MAP kinase inhibitors. After 4 h, cells were washed vigorously with warm
Hank’s balanced salt solution to remove extracellular bacteria. To determine
bacterial uptake, macrophages were lysed by addition of 0.1% saponin. Lysates
were serially diluted and plated on agar (see above). For the investigation of
bacterial growth, parallel cultures were maintained for 7 days in 500 l of
medium (at day three, 500 l of fresh medium was added). Subsequently, cells
were washed, lysed, diluted, and plated for CFU determination as described
above. In several experiments donor-dependent detachment of macrophages was
noted to a varying degree after 7 days of infection. To take into account potential
differences in the survival rates of macrophages infected with mycobacterial
strains of different virulences under different assay conditions, the actual amount
of mycobacteria inside macrophages still present at the end of culture was
determined. To this end, adherent macrophages were quantified at the end point
of infection as follows: in each well, two identical areas (each 2 mm2 in size)
equidistant from the center of the well (1 mm above and 1 mm below) were
defined using a superimposed grid. Within any one individual well, these two
indicator areas showed comparable densities and distributions of macrophages.
Using a digital camera (Visicam 1300; Vitron Systems GmbH, Munich, Ger-
many) attached to a microscope (DMIRB, Leica Microsystems AG, Wetzlar,
Germany) and imaging software (MetaMorph 3.0; Universal Imaging, West
Chester, Pa.), the indicator areas were photographed and macrophages present
in these areas were counted manually on printouts. Subsequently, CFU counts
per well were divided by the mean number of macrophages in these indicator
areas. This index allows direct comparison of mycobacteria surviving within
macrophages of different wells and defines the relative CFU, shown below in Fig.
1 and 3.
Determination of MAP kinase phosphorylation. A total of 4  105 human
macrophages (at a concentration of 8 105 per ml) were stimulated with 2 106
CFU of M. avium or 10 ng of LPS/ml as a control for 30 min. Cultures were lysed
by addition of 100 l of 2 sample buffer (125 mM Tris, pH 6.8; 4% sodium
dodecyl sulfate [SDS]; 20% glycerol; 100 mM dithiothreitol; 0.05% bromphenol
blue). Samples were loaded onto an SDS–12% polyacrylamide gel and run at 100
mA for 1 h. Proteins were transferred onto a nitrocellulose membrane (Sartorius,
Go¨ttingen, Germany) by wet blotting at 1.5 mA/cm2 (4°C) for 1.5 h. After
blocking with 5% (wt/vol) nonfat dry milk (Gluecksklee, Nestle´, Frankfurt,
Germany) in Tris-buffered saline containing 0.1% Tween 20 (Sigma) (TTBS),
membranes were incubated with the primary antibody (p38, phospho-p38,
ERK1/2, and phospho-ERK1/2; New England Biolabs, Schwalbach, Germany)
overnight at 4°C. Blots were washed three times with TTBS and incubated for 1 h
with the horseradish peroxidase-conjugated goat anti-rabbit immunoglobulin G
(Dianova, Hamburg, Germany). Membranes were developed using a chemilu-
minescence assay (ECL; Pharmacia-Amersham, Freiburg, Germany) and subse-
quently exposed to chemiluminescence film (Pharmacia-Amersham).
Detection of cytokine release. A total of 4  105 human macrophages (at a
concentration of 8  105 per ml) were stimulated with 2  106 CFU of M. avium
or 10 ng of LPS/ml as a control. Culture supernatants of stimulated macrophages
were harvested at the time points indicated and stored at 20°C until analysis.
Sandwich enzyme-linked immunosorbent assays (ELISAs) were used for detect-
ing tumor necrosis factor alpha (TNF-; H. Gallati, Intex, Muttenz, Switzerland)
(11) and interleukin-10 (IL-10) (R&D Systems) in culture supernatants. Assays
were performed as recommended by the manufacturers.
Statistical analysis. The effects of p38 and ERK inhibition on intramacro-
phage mycobacterial replication and cytokine secretion were analyzed in infec-
tion experiments with six and three different donors, respectively. For statistical
analysis, data from independent infection experiments were log transformed
prior to analysis. Two-factorial analysis of variance with the donor as blocking
factor and subgroup analysis were performed by using a one-sided t test (JMP
4.0; SAS Institute, Cary, N.C.). The -error was corrected according to the
Bonferroni-Holm procedure. Cytokine concentrations under different culture
conditions were correlated to concentrations in control cultures (normalized to
100%). Data obtained from independent experiments were compared by using a
t test for multiple comparisons and are represented as the mean  standard
deviation (SD).
RESULTS
M. avium 2151 SmT and SmO show different growth kinetics
in human macrophages in vitro. Human macrophages were
infected with either the smooth transparent (SmT) or the
smooth opaque (SmO) morphotype of M. avium 2151. After
4 h, both morphotypes were phagocytosed at comparable num-
bers (Fig. 1A) with a multiplicity of infection averaging 1 my-
cobacterium per 12 to 14 macrophages. Mycobacterial growth
in human macrophages 7 days after infection is shown in Fig.
1B. The SmT morphotype replicated extensively compared to
the SmO morphotype, which was gradually eliminated during
infection. In the absence of macrophages, both morphotypes
replicated to a comparable extent in cell culture medium (data
not shown). Although the two morphotypes differentially per-
sisted in infected cultures, macrophage numbers were identical
7 days postinfection (Fig. 1B). When depicted as CFU related
to macrophage number (relative CFU, as described in Mate-
rials and Methods), a 774-fold increase in CFU of SmT above
that of SmO was observed (Fig. 1C).
M. avium-induced MAP kinase activation is inversely corre-
lated to in vitro virulence of the M. avium morphotypes. In
order to investigate whether the divergent intracellular repli-
4962 BLUMENTHAL ET AL. INFECT. IMMUN.
 o
n
 O
ctober 18, 2015 by University of Queensland Library
http://iai.asm
.org/
D
ow
nloaded from
 
cation rates of the two morphotypes were related to differential
host cell activation, M. avium was added to human macrophage
cultures and phosphorylation of the p38 and ERK1/2 (p44/p42)
MAP kinases was analyzed. In macrophages infected with the
highly replicative SmT morphotype, only a weak phosphoryla-
tion of both p38 and ERK1/2 was observed. In contrast, a
markedly stronger signal of p38 and ERK1/2 phosphorylation
was detected after addition of the poorly persisting SmO mor-
photype to the macrophages (Fig. 2). Both M. avium morpho-
types induced p38 and ERK1/2 phosphorylation with identical
kinetics, starting with detectable phosphorylation as early as 15
min (data not shown) and with a maximum at 30 to 45 min.
Thus, the magnitude of MAP kinase phosphorylation induced
by M. avium was inversely correlated to intracellular mycobac-
terial replication.
ERK1/2, but not p38, activity is involved in control of intra-
cellular M. avium replication in human macrophages. In order
to investigate whether MAP kinase activity was directly in-
volved in mycobacterial survival, infection experiments were
performed in the presence or absence of highly specific phar-
macologic inhibitors of MAP kinase signaling cascades.
PD98059 is a well-established inhibitor of the ERK1/2 pathway
that acts by repressing activation of MEK-1, the kinase up-
stream of p42 and p44. The pyridinyl imidazole SB203580
specifically inhibits p38 activity by binding to the ATP-binding
site and inhibiting enzyme activity but not p38 phosphorylation
(reviewed in reference 8 and references therein).
The presence of MAP kinase inhibitors did not significantly
affect mycobacterial uptake into macrophages 4 h postinfec-
tion compared to cultures with no additive or with DMSO as
solvent control (data not shown). After 7 days, CFU of the
highly replicative SmT morphotype had substantially increased
in cultures containing PD98059 (10 M), whereas the presence
of SB203580 did not have any effect even at concentrations up
to 10 M. The gradual elimination of the SmO morphotype
from macrophages was unaffected after coincubation with ei-
ther PD98059 or SB203580 (Fig. 3A). In order to validate the
observed growth-enhancing effect of PD98059 on the highly
replicative variant 2151 SmT, parallel cultures were infected
with another strain of M. avium (SE01) which also showed
extensive growth in macrophages. Again, the presence of
PD98059 led to an increase in mycobacterial CFU relative to
macrophage numbers, while SB203580 did not alter intracel-
lular growth of this strain (Fig. 3B). DMSO alone had no
influence on mycobacterial growth. In addition, a direct effect
of PD98059 and SB203580 on mycobacterial growth was ex-
cluded by cultivation of mycobacteria in the presence of MAP
kinase inhibitors but in the absence of macrophages (data not
shown).
The same set of experiments was performed independently
for six different donors. Although there was substantial donor-
dependent variation with regard to the extent of mycobacterial
proliferation within macrophages, the presence of PD98059
led to a significant increase in colony counts of the highly
proliferative strains 2151 SmT (Fig. 3C) and SE01 (Fig. 3D).
These results were confirmed by using a second, more potent
FIG. 1. Uptake and intracellular replication of M. avium 2151 SmT and SmO in human macrophages. Human monocyte-derived macrophages
were infected with the smooth transparent (SmT) or the smooth opaque (SmO) morphotype of M. avium strain 2151. (A) CFU counts in lysed
macrophages were determined 4 h after infection. (B) Intracellular mycobacterial replication was determined by CFU counts after 7 days and
compared to initial intracellular bacterial numbers (dotted line). Macrophage (M) numbers in indicator areas were determined. (C) To
meaningfully compare actual intracellular mycobacterial replication rates within macrophages, CFU were correlated to macrophage numbers at
day 7. Relative CFU were calculated by dividing CFU per well by the number of macrophages in indicator areas (as described in Materials and
Methods). Means of duplicates  SD of one typical experiment out of six (six different donors) are shown.
FIG. 2. Differential phosphorylation of MAP kinases by M. avium
2151 SmT and SmO. Human monocyte-derived macrophages were
incubated with either the smooth transparent (SmT) or smooth
opaque (SmO) morphotype of M. avium strain 2151 or LPS for 30 min.
Cells were lysed, and aliquots of cell lysates were separated by SDS-
polyacrylamide gel electrophoresis and immunoblotted onto nitrocel-
lulose membranes. The membranes were incubated with specific anti-
phospho-ERK1/2 and anti-phospho-p38 antibodies and then incubated
with a peroxidase-coupled secondary antibody. Visualization was per-
formed by enhanced chemiluminescence. As controls, the amounts of
total ERK1/2 and p38 were detected in the same lysates. One repre-
sentative experiment out of three independent experiments (three
different donors) is shown.
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MEK-1 inhibitor, U0126 (data not shown). In contrast, the
presence of PD98059 did not significantly alter CFU counts of
the SmO morphotype, and mycobacterial growth was re-
pressed in all cases (Fig. 3C). The presence of SB203580 con-
sistently had no significant effect on intramacrophage replica-
tion rates of any of the M. avium strains tested (Fig. 3C and D).
Therefore, activation of the ERK1/2 pathway seems to be
critically involved in controlling intracellular mycobacterial
replication of highly replicative M. avium strains.
Cytokines are only partially involved in control of intramac-
rophage growth of M. avium. To gain further insight into the
mechanisms by which inhibition of the ERK1/2 pathway might
exert its intramacrophage growth-promoting effect on certain
M. avium strains, the magnitude of cytokine secretion induced
by M. avium strains differing in their virulence was analyzed in
the presence and absence of MAP kinase inhibitors. To this
end, human macrophages were infected with M. avium 2151
SmT or SmO and the levels of the macrophage-activating cy-
tokine TNF- and the macrophage-deactivating cytokine IL-10
into the supernatant were analyzed. Both M. avium morpho-
types induced the release of TNF- and IL-10 in a dose-
dependent manner (Fig. 4). The highly replicative SmT mor-
photype, which led to only a weak MAP kinase activation,
induced the release of significantly smaller amounts (up to
three times less than SmO) of TNF- and IL-10. In contrast,
the SmO morphotype, a strong activator of MAP kinases, led
to a strong induction of cytokine release. Therefore, M. avium-
induced TNF- and IL-10 release reflected the extent of MAP
kinase activation by morphotypes differing in their intracellular
replication rates in vitro.
Since inhibition of p38 and ERK1/2 activities had differ-
ent effects on the intracellular replication rates of the M.
avium strains examined, it appeared possible that inhibition
of p38 and ERK1/2 activities in macrophages infected with
these strains would have strain- or virulence-dependent ef-
fects on TNF- and IL-10 secretion. Our data (Fig. 5)
clearly show, however, that the effect of MAP kinase inhi-
bition on cytokine expression was not virulence specific. In
fact, a differential effect of MAP kinase inhibition on TNF-
and IL-10 secretion, previously demonstrated by our labo-
FIG. 3. PD98059, but not SB203580, enhances intracellular mycobacterial growth. Cultures of human monocyte-derived macrophages were
preincubated with 3 or 10 M PD98059 (F) or SB203580 (E) or 0.1% (vol/vol) DMSO as solvent control for 60 min. Macrophages were infected
with M. avium 2151 smooth transparent (SmT) or smooth opaque (SmO) (A) or M. avium strain SE01 (B). The number of intracellular viable
bacteria correlated to macrophage numbers (relative CFU) was determined 7 days postinfection. Values represent means of duplicates  SD of
one representative experiment out of six. (C and D) Results obtained from different donors. Macrophages were preincubated with 10 M MAP
kinase inhibitor or 0.1% (vol/vol) DMSO. Cells were infected with 2151 SmT or 2151 SmO (C) or with SE01 (D). For each donor, CFU counts
7 days postinfection were correlated to macrophage numbers and are shown as relative CFU. The boxes indicate the 25th and 75th percentiles.
Whiskers above and below the boxes indicate the 90th and 10th percentiles. Medians are marked. All outlying points are graphed. Data shown were
obtained from six independent experiments (six different donors) performed in duplicate. *, P 	 0.05; n.s., not significant.
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ratory for M. avium strain SE01 (26), was seen for both
morphotypes of strain 2151 and was, therefore, independent
of the virulence of the M. avium isolate. TNF- release was
significantly reduced by PD98059 in a dose-dependent man-
ner after stimulation with either M. avium strain. In con-
trast, IL-10 formation was not inhibited in the presence of
PD98059 (Fig. 5A). Inhibition of p38 activity by cocultiva-
tion with SB203580 did not reduce TNF- formation in
macrophages induced by either morphotype. Although sta-
tistically not significant, M. avium-induced TNF- release
was usually enhanced. Strain 2151 SmT always induced little
IL-10 formation (Fig. 4). Usage of SB203580 further re-
duced IL-10 release, although effects were not found to be
statistically significant because all measured IL-10 amounts
were near the lower detection limit of the ELISA (Fig. 5B).
The highly activating smooth opaque morphotype induced
the formation of higher amounts of IL-10. In this case, IL-10
release was significantly reduced in the presence of
SB203580 (Fig. 5B).
DISCUSSION
The aim of this study was to analyze whether the extent of
MAP kinase signaling induced by various M. avium strains and
morphotypes would be a determinant for their subsequent intra-
cellular survival. We found that M. avium-induced activation of
ERK1/2 and p38 MAP kinases was inversely correlated to the
virulence of the infecting mycobacterial variant in vitro. Inhibition
of ERK1/2 activation enhanced intracellular multiplication of
highly replicative strains, whereas p38 activation was not involved
in controlling intracellular growth or survival of either high-level
or low-level replicating variants of M. avium. However, the regu-
lation of M. avium-induced cytokine release was independent of
mycobacterial virulence. We found ERK1/2 activation essential
for TNF- formation, whereas p38 activity, but not the ERK1/2
pathway, was involved in IL-10 release.
Infection with M. avium, a facultative intracellular opportu-
nistic pathogen in humans, is a well-studied model for myco-
bacterial infections. A major phenotypic characteristic of M.
FIG. 4. TNF- and IL-10 release in cultures of human macro-
phages infected with M. avium strain 2151 SmT or SmO. Human
monocyte-derived macrophages were incubated with increasing num-
bers of M. avium 2151 smooth transparent (SmT) or smooth opaque
(SmO) or LPS as positive control. Supernatants were harvested after
18 h (TNF-) and additionally from the same cultures 44 h (IL-10)
postinfection. Cytokine concentrations were measured by ELISA.
Means of duplicates ( SD) of one representative experiment out of
three (three different donors) are shown.
FIG. 5. PD98059 reduces M. avium-induced TNF- formation;
SB203580 reduces M. avium-induced IL-10 release. Human monocyte-
derived macrophages were preincubated with medium containing 3 or
10 M PD98059 (A) or SB203580 (B), or 0.1% (vol/vol) DMSO as
solvent control for 60 min. Cultures were incubated with M. avium
2151 smooth transparent (SmT) or smooth opaque (SmO) or LPS as
a positive control. Supernatants were harvested after 18 h (TNF-) or
44 h (IL-10), and cytokine concentrations were determined by ELISA.
To compare results from different experiments showing substantial
donor-dependent variation of cytokine concentrations, secreted
amounts of TNF- and IL-10 are shown as percent of control cultures
stimulated in the presence of DMSO (normalized to 100%). Data
shown are the mean  SD of three independent experiments (three
different donors) performed in duplicate. *, P 	 0.05; **, P 	 0.005;
***, P 	 0.0005; n.s., not significant.
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avium isolates is their ability to appear in different colony
morphotypes: smooth (either transparent or opaque) or rough
(reviewed in reference 14). Although morphotypes of the same
strain are very closely related, previous studies demonstrated
that the smooth transparent variant is usually better able to
survive and grow intracellularly than the opaque morphotype
(10, 21). With regard to the M. avium morphotypes used in this
study (2151 SmT and SmO), this pattern has been confirmed
both in murine macrophages and in a mouse model of infec-
tion (1, 2). Our results extend these findings to human mono-
cyte-derived macrophages. This is not trivial, because in the
case of the M. tuberculosis strain H37Rv and its avirulent vari-
ant H37Ra, growth patterns in mice and murine macrophages
are not reflected by their in vitro growth characteristics in
human macrophages (24). Why different morphotypes of M.
avium either possess or lack the capacity for intracellular per-
sistence is entirely unknown, but the responsible mechanisms
likely involve modulation of intracellular signaling pathways
(reviewed in reference 23).
Focusing on MAP kinase signaling events, we observed ac-
tivation of both ERK1/2 and p38 in response to the two closely
related morphotypes of M. avium 2151. Since the magnitude of
MAP kinase activation was inversely correlated to the intra-
macrophage replication potential of these strains, we hypoth-
esized that ERK1/2 and p38 signaling might indeed play a
direct role in controlling the growth of these strains.
A variety of commercially available compounds have proven
to be powerful tools for functional analysis of particular cell
signaling elements (8). The highly specific inhibitors PD98059
and SB203580 have previously been used to demonstrate in-
volvement of ERK1/2 and p38 MAP kinase pathways in uptake
and persistence of pathogenic viruses and bacteria (16, 29).
Regarding intracellular mycobacterial replication, inhibition
of the ERK1/2 pathway led to an increased growth of M. avium
2151 SmT (and also of another, highly replicative strain, SE01)
within human macrophages. This growth-enhancing effect was,
however, not observed for the related SmO morphotype of the
same strain. These data indicate that replication of some my-
cobacterial strains, such as M. avium 2151 SmO, can easily be
controlled by macrophages, even in the presence of drugs in-
terfering with essential signaling pathways. In this respect, it is
interesting that ERK1/2 activity also seems not to be involved
in controlling the replication of another facultative intracellu-
lar bacterium, L. monocytogenes (16). In contrast, other myco-
bacterial variants, like M. avium 2151 SmT and SE01, are more
resistant to growth control by the macrophage. In macrophages
infected with these strains, additional repression of the
ERK1/2 pathway might unbalance innate defense mechanisms
to an extent more favorable to mycobacterial replication. No-
tably, inhibition of p38 activity in human macrophages did not
significantly affect intracellular replication of any of the M.
avium variants used. From these results, we conclude that p38
activity is not critically involved in the control of mycobacterial
growth in infected macrophages in vitro. Parallel infection
studies performed in bone marrow-derived macrophages of
C57BL/6 mice (A. Blumenthal et al., unpublished observa-
tions) corroborate our data and show that our results are not
restricted to the human system.
One possible mechanism by which the magnitude of MAP
kinase activity may influence intracellular mycobacterial repli-
cation could be the induction of cytokines. With regard to
TNF-, several previous studies have shown an inverse corre-
lation between the extent of TNF- release in reaction to M.
avium and the virulence of the infecting strain or morphotype.
Therefore, the hypothesis was put forth that certain M. avium
isolates are more virulent because they induce only little
TNF- in vitro (10, 27). With respect to the two morphotypes
of M. avium 2151, our data confirm this hypothesis and, in
addition, provide a plausible explanation at the signal trans-
duction level. Thus, the virulent morphotype induced less
MAP kinase phosphorylation than the avirulent morphotype.
Virulence may therefore simply be a reflection of an intrinsic
inability of certain mycobacterial strains to stimulate macro-
phages. However, it is intriguing to speculate that virulence
may also reside in the capacity of some mycobacterial strains to
inhibit early signal transduction events, such as MAP kinase
phosphorylation.
PD98059 and SB203580 were used to analyze whether MAP
kinase activation would affect M. avium-induced cytokine re-
lease in a virulence-dependent way. As shown, independent of
the morphotype used, TNF- production was critically depen-
dent on the activation of the ERK1/2 pathway, whereas p38
activity, and not ERK1/2, was involved in IL-10 release, which
corroborates earlier studies using another well-replicating M.
avium strain, SE01 (26).
We suggest that differential regulation of pro- and antiin-
flammatory mediators at the level of MAP kinase activity may
represent a general macrophage response to M. avium (inde-
pendent of the strain or morphotype) and, possibly, to other
virulent and avirulent mycobacterial species.
Previous studies described contradictory effects of neutral-
ization of endogenous IL-10 in vitro (9, 30). In our system,
inhibition of endogenous IL-10 by SB203580 was not accom-
panied by enhanced growth of any M. avium strain tested. We
conclude that IL-10 release by infected macrophages may not
be critical in intracellular growth control of M. avium. Inhibi-
tion of the ERK1/2 signaling cascade in M. avium 2151 SmT-
or SE01-infected macrophages was followed by diminished
TNF- release and enhanced intracellular mycobacterial rep-
lication. An important role for TNF- in the control of M.
avium replication in vitro has previously been demonstrated
(1). Furney et al. (10) showed a significant inhibitory effect of
TNF- on intracellular replication only for extensively repli-
cating M. avium variants, whereas the effect on low-level-rep-
licating mycobacteria was minimal. Thus, early inhibition of
TNF- release may be one of the mechanisms by which
PD98059 promotes intramacrophage growth of some highly
replicative strains of M. avium.
A number of arguments, however, strengthen the view that
control of M. avium replication insides macrophages involves
more than stimulation by TNF-. First, infection of macrophages
with M. avium SE01 induces TNF- levels comparable to those
achieved by the easily controlled 2151 SmO (26; also data not
shown). Yet, SE01 is a highly replicative M. avium strain and, in
this respect, quite similar to 2151 SmT, which induces only low
amounts of TNF-. Second, inhibition of the ERK1/2 pathway
markedly reduced TNF- secretion induced by 2151 SmO, yet
intracellular survival rates stayed low for this isolate.
Since the growth-enhancing effect of ERK1/2 pathway inhi-
bition cannot be entirely explained by modulation of TNF-
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levels, it would appear that M. avium-induced activation of the
ERK1/2 signaling cascade is involved in other, TNF--inde-
pendent cellular processes that ultimately lead to restriction of
mycobacterial growth. Alternatively, it is entirely possible that
M. avium strains simply differ in their susceptibility to TNF--
induced bacteriostatic mechanisms and that, for some strains,
higher TNF- levels are required to achieve growth inhibition
than for others.
Our present study demonstrates that, for M. avium infection,
the relationship between macrophage activation (as reflected
by MAP kinase phosphorylation), TNF- and IL-10 secretion,
and bacteriostasis is more complex than previously thought.
We have identified ERK1/2 signaling as a critical pathway for
growth restriction of some M. avium strains. We further un-
covered that ERK1/2-independent mechanisms, as well as
TNF--independent mechanisms, must exist to curtail the
growth of other M. avium variants. It would appear that novel
strategies for antimycobacterial immunotherapy will require a
more thorough understanding of the subtleties of the host-
pathogen relationship.
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